Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-04-02

Clinical Trial Update: Study to Evaluate the Effect of GSK3640254 on the Pharmacokinetics of Tenofovir Alafenamide/Emtricitabine [Phase 1]

View source ↗

Summary

Phase 1 trial assessing pharmacokinetics of Tenofovir Alafenamide/Emtricitabine with GSK3640254; completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GSK3640254
  • Tenofovir Alafenamide/Emtricitabine

Snippet

Sponsor: ViiV Healthcare | Conditions: HIV Infections | Phase 1 | Status: COMPLETED | Results posted: 2020-04-02